Bolt Biotherapeutics, Inc.

US$6.54As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BOLTHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (53.86%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.82
PE TTM —
TSR TTM 13.54%
Mkt cap US$16.91M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.06
23.28%
(55.95%)
Hold 8|8|11|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.07
22.42%
27.24%
17.40%
6.89%
Revenue$M
0.943
0.941
0.976
0.974
9.93%
8.63%
11.18%
6.79%
Peers (US$16.91M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.027
0.455
0.369
EBIT/Intx
0.667
0.174
0.160
Own earn%
40.32
(100.58)
(101.76)
Sh yield%
55.20
44.89
45.37
Owners
Insiders/Inst%
4.56
88.13
Short interest%
3.31
SBC / revenue%
2.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
30–36
$1 testx
−0.1
Incr. ROIC%
35